A licensed version of Bisoprolol 1mg/ml oral solution sugar free was launched by Aspire Pharma Ltd in August 2025. However, at the same time an unlicensed version of Bisoprolol 5mg/5ml oral solution was listed in Part VIIIB of the Drug Tariff. According to the Drug Tariff rules, any generically written prescription for Bisoprolol 5mg/5ml (or 1mg/ml) oral solution would be reimbursed according to the price listed in Part VIIIB of the August 2025 Drug Tariff.
Due to the availability of a UK licensed product in August, the Department of Health and Social Care (DHSC) has made adjustments to payments for the prescriptions claimed in August 2025 as follows:
| Prescribed product | Endorsed as | Reimbursement for prescriptions dispensed in August 2025 |
| Bisoprolol 5mg/5ml oral solution | Aspire Pharma Ltd | Reimbursement based on the UK list price of Aspire Pharma Ltd product |
|
Bisoprolol 5mg/5ml oral solution or Bisoprolol 5mg/5ml oral solution sugar free |
Endorsed as a Part VIIIB special | Reimbursement based on August Drug Tariff Part VIIIB price |
| Bisoprolol 5mg/5ml oral solution (Drug Tariff Special Order) | Endorsed as a Part VIIIB special | Reimbursement based on August Drug Tariff Part VIIIB price. |
| Bisoprolol 5mg/5ml oral solution (Drug Tariff Special Order) | Aspire Pharma Ltd | Reimbursement based on August Drug Tariff Part VIIIB price. |
| Bisoprolol 5mg/5ml oral solution sugar free (Drug Tariff Special Order) | Endorsed as a Part VIIIB special | Reimbursement based on August Drug Tariff Part VIIIB price |
|
Bisoprolol 1mg/ml oral solution sugar free or Bisoprolol 1mg/ml oral solution sugar free (Aspire Pharma Ltd) |
Aspire Pharma Ltd | Reimbursement based on the UK list price of Aspire Pharma Ltd product |
|
Bisoprolol 1mg/ml oral solution or Bisoprolol 1mg/ml oral solution sugar free |
No endorsement present | NHSBSA will contact the pharmacy to establish what was supplied and reimburse accordingly. |
The adjustment will be applied automatically for August 2025 and will appear on the relevant Schedule of Payments.
Pharmacy teams should note the following products have been removed from Part VIIIB of the September 2025 Drug Tariff:
- Bisoprolol 5mg/5ml oral solution
- Bisoprolol 5mg/5ml oral suspension
Please see Community Pharmacy England’s September Drug Tariff Watch, which includes details of additions, deletions and category and price changes for more information.
The post Retrospective price adjustment for Bisoprolol 5mg/5ml oral solution for August 2025 appeared first on Community Pharmacy England.